Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Akt1 and dCIZ1 promote cell survival from apoptotic caspase activation during regeneration and oncogenic overgrowth.

Tytuł:
Akt1 and dCIZ1 promote cell survival from apoptotic caspase activation during regeneration and oncogenic overgrowth.
Autorzy:
Sun G; The Key Laboratory of Experimental Teratology, Ministry of Education and Department of Anatomy and Histoembryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. .; Molecular, Cellular, and Developmental Biology Department, University of California, Santa Barbara, CA, 93106, USA. .
Ding XA; Molecular, Cellular, and Developmental Biology Department, University of California, Santa Barbara, CA, 93106, USA.
Argaw Y; Molecular, Cellular, and Developmental Biology Department, University of California, Santa Barbara, CA, 93106, USA.
Guo X; Molecular, Cellular, and Developmental Biology Department, University of California, Santa Barbara, CA, 93106, USA.
Montell DJ; Molecular, Cellular, and Developmental Biology Department, University of California, Santa Barbara, CA, 93106, USA. .
Źródło:
Nature communications [Nat Commun] 2020 Nov 12; Vol. 11 (1), pp. 5726. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Cell Survival*
Carcinogenesis/*genetics
Caspases/*metabolism
Proto-Oncogene Proteins c-akt/*metabolism
Animals ; Apoptosis ; Cell Death ; Drosophila/genetics ; Drosophila Proteins/genetics ; Drosophila Proteins/metabolism ; Humans ; Nuclear Proteins ; Oncogenes ; RNA Interference ; Transcription Factors ; Wings, Animal ; Zinc Fingers
References:
Nat Med. 2011 Jul 03;17(7):860-6. (PMID: 21725296)
PLoS One. 2012;7(4):e34063. (PMID: 22509270)
Sci Signal. 2010 Feb 23;3(110):ra13. (PMID: 20179271)
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20539-20544. (PMID: 31548372)
Cell Death Differ. 2017 Aug;24(8):1390-1400. (PMID: 28362431)
Cancer Res. 2006 Nov 15;66(22):11021-9. (PMID: 17108141)
J Invest Dermatol. 2014 Jun;134(6):1686-1692. (PMID: 24434746)
Cancer Metastasis Rev. 2018 Sep;37(2-3):227-236. (PMID: 29858742)
PLoS Biol. 2004 Jan;2(1):E15. (PMID: 14737191)
Science. 1994 Apr 29;264(5159):677-83. (PMID: 8171319)
Curr Biol. 2015 Mar 2;25(5):577-88. (PMID: 25702581)
Cell Oncol (Dordr). 2019 Oct;42(5):645-661. (PMID: 31147963)
Dev Dyn. 2012 May;241(5):831-41. (PMID: 22438309)
Biomolecules. 2016 Dec 27;7(1):. (PMID: 28036012)
Cell Rep. 2020 Jun 9;31(10):107731. (PMID: 32521256)
Cell. 2004 Apr 2;117(1):117-29. (PMID: 15066287)
Mol Cell Biol. 2012 Sep;32(18):3695-706. (PMID: 22801366)
Front Biosci (Landmark Ed). 2015 Jan 01;20(4):705-15. (PMID: 25553473)
Oncotarget. 2017 Dec 23;9(9):8629-8641. (PMID: 29492222)
PLoS Genet. 2015 Oct 23;11(10):e1005595. (PMID: 26496642)
Mol Oncol. 2015 Jan;9(1):105-14. (PMID: 25156550)
Annu Rev Genet. 2012;46:289-310. (PMID: 22934642)
Nat Methods. 2009 Aug;6(8):603-5. (PMID: 19633663)
J Cell Sci. 2005 Jan 1;118(Pt 1):101-12. (PMID: 15585571)
J Cell Biol. 2000 Oct 30;151(3):483-94. (PMID: 11062251)
Gene. 2019 Nov 30;719:143946. (PMID: 31252164)
Curr Opin Cell Biol. 2018 Dec;55:150-157. (PMID: 30208354)
Cell Death Dis. 2013 Jul 11;4:e725. (PMID: 23846227)
Int J Cancer. 2018 Aug 15;143(4):921-930. (PMID: 29524226)
Development. 2018 Dec 4;145(23):. (PMID: 30413561)
BMC Dev Biol. 2010 Sep 02;10:94. (PMID: 20813047)
Dev Cell. 2003 May;4(5):687-97. (PMID: 12737804)
Cold Spring Harb Perspect Biol. 2012 Aug 01;4(8):a008797. (PMID: 22855725)
Neurobiol Aging. 2018 Feb;62:180-190. (PMID: 29154038)
Curr Biol. 2010 Apr 13;20(7):643-8. (PMID: 20346676)
Dev Biol. 2010 Feb 1;338(1):76-85. (PMID: 19766622)
Biol Open. 2017 Jan 15;6(1):92-99. (PMID: 27934662)
BMC Biol. 2017 Oct 24;15(1):92. (PMID: 29065871)
Biochem Biophys Res Commun. 1999 Oct 22;264(2):457-64. (PMID: 10529385)
Dev Cell. 2009 Aug;17(2):279-89. (PMID: 19686688)
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16166-71. (PMID: 20805468)
Tumour Biol. 2016 Apr;37(4):4735-42. (PMID: 26515335)
J Cell Biol. 2017 Oct 2;216(10):3355-3368. (PMID: 28768686)
Mol Med Rep. 2013 Dec;8(6):1630-4. (PMID: 24126760)
Curr Biol. 2004 Jul 27;14(14):1262-6. (PMID: 15268856)
Mol Cell Biol. 2012 Nov;32(22):4523-33. (PMID: 22949508)
Cell. 2017 Apr 20;169(3):381-405. (PMID: 28431241)
Mol Biol Cell. 2012 Jun;23(12):2240-52. (PMID: 22535522)
Cell. 2007 Jun 29;129(7):1261-74. (PMID: 17604717)
Dev Biol. 2011 Feb 1;350(1):139-51. (PMID: 21145886)
J Cell Biol. 2012 Feb 20;196(4):513-27. (PMID: 22351928)
Nat Rev Cancer. 2016 Aug;16(8):539-48. (PMID: 27364482)
Nat Cell Biol. 2011 Aug 01;13(8):877-83. (PMID: 21808241)
Development. 2004 Nov;131(22):5591-8. (PMID: 15496444)
Elife. 2016 Apr 08;5:. (PMID: 27058168)
Int J Mol Sci. 2016 Feb 05;17(2):212. (PMID: 26861296)
Trends Cell Biol. 1998 Jul;8(7):267-71. (PMID: 9714597)
Sci Rep. 2016 Feb 03;6:20471. (PMID: 26839216)
Diabetes. 2010 Nov;59(11):2799-808. (PMID: 20682686)
Genes Cancer. 2017 Sep;8(9-10):682-694. (PMID: 29234486)
Elife. 2015 Feb 26;4:. (PMID: 25719210)
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5691-6. (PMID: 9159134)
Nat Rev Drug Discov. 2014 Feb;13(2):140-56. (PMID: 24481312)
Tumour Biol. 2016 Aug;37(8):11073-9. (PMID: 26906552)
Genes Dev. 2002 Sep 1;16(17):2286-99. (PMID: 12208851)
Nat Commun. 2019 Jan 28;10(1):460. (PMID: 30692537)
Mol Cell. 2015 Apr 16;58(2):284-96. (PMID: 25866249)
J Nucl Med. 2010 Feb;51(2):259-67. (PMID: 20124049)
Sci Rep. 2015 Mar 11;5:9015. (PMID: 25757939)
Curr Biol. 2016 Mar 7;26(5):670-7. (PMID: 26898471)
Cell. 2004 Apr 2;117(1):107-16. (PMID: 15066286)
Elife. 2017 Aug 30;6:. (PMID: 28853394)
Oncotarget. 2015 Oct 20;6(32):32353-67. (PMID: 26431328)
Cell Death Differ. 2004 Apr;11(4):439-47. (PMID: 14713960)
Tumour Biol. 2015 Apr;36(4):2583-91. (PMID: 25427641)
Nature. 2010 Apr 22;464(7292):1201-4. (PMID: 20357768)
Grant Information:
DP1 CA195760 United States CA NCI NIH HHS
Substance Nomenclature:
0 (Ciz1 protein, human)
0 (Drosophila Proteins)
0 (GAL4 protein, Drosophila)
0 (Nuclear Proteins)
0 (Transcription Factors)
EC 2.7.11.1 (AKT1 protein, human)
EC 2.7.11.1 (Akt1 protein, Drosophila)
EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)
EC 3.4.22.- (Caspases)
Entry Date(s):
Date Created: 20201113 Date Completed: 20201130 Latest Revision: 20240212
Update Code:
20240212
PubMed Central ID:
PMC7664998
DOI:
10.1038/s41467-020-19068-2
PMID:
33184261
Czasopismo naukowe
Apoptosis is an ancient and evolutionarily conserved cell suicide program. During apoptosis, executioner caspase enzyme activation has been considered a point of no return. However, emerging evidence suggests that some cells can survive caspase activation following exposure to apoptosis-inducing stresses, raising questions as to the physiological significance and underlying molecular mechanisms of this unexpected phenomenon. Here, we show that, following severe tissue injury, Drosophila wing disc cells that survive executioner caspase activation contribute to tissue regeneration. Through RNAi screening, we identify akt1 and a previously uncharacterized Drosophila gene CG8108, which is homologous to the human gene CIZ1, as essential for survival from the executioner caspase activation. We also show that cells expressing activated oncogenes experience apoptotic caspase activation, and that Akt1 and dCIZ1 are required for their survival and overgrowth. Thus, survival following executioner caspase activation is a normal tissue repair mechanism usurped to promote oncogene-driven overgrowth.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies